Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats

Digestive Diseases and Sciences

Volumn 52, Issue 4, 2007, Pages 988-994

  Hagiwara, Tadashi ^a   Mukaisho, Ken Ichi ^a   Ling, Zhi Qiang ^a   Sakano, Takayo ^a   Sugihara, Hiroyuki ^a   Hattori, Takanori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Long term; Omeprazole; Proton pump inhibitor; Rat; Rebamipide

Indexed keywords

AMYLASE; BILE ACID; GASTRIN; OMEPRAZOLE; PROTON PUMP INHIBITOR; REBAMIPIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID HYPERSECRETION; BILE ACID SYNTHESIS; CONTROLLED STUDY; GASTRIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MALE; METAPLASIA; NONHUMAN; PRIORITY JOURNAL; RAT; RISK REDUCTION; STOMACH MUCOSA; TREATMENT DURATION;

ALANINE; ANIMALS; ANTI-ULCER AGENTS; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; MALE; OMEPRAZOLE; PROTON PUMPS; QUINOLONES; RATS; RATS, WISTAR;

EID: 33947581607     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9415-7     Document Type: Article

References (34)

1. Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG (1995) Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. AM J Gastroenterol 90:1401-1406
2. Yoshimura K, Delbarre SG, Kraus E, Boland CR (1996) The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach. Aliment Pharmacol Ther 10:111-117
3. Viste A, Ovrebo K, Maartmann-Moe H, Waldum H (2004) Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer 7:31-35
4. Wetscher GJ, Hinder RA, Smyrk T, Perdikis G, Adrian TE, Profanter C (1999) Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 44:1132-1135
5. Stolte M, Bethke B, Ruhl G, Ritter M (1992) Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol 30:134-138
6. Stolte M, Bethke B, Seifert E, Armbrecht U, Lutke A, Goldbrunner P, Rabast U (1995) Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol 33:146-149
7. Stolte M, Meining A, Seifert E, Alexandridis T (2000) Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. Pathol Res Pract 196:9-13
8. Raghunath AS, O'Morain C, McLoughlin RC (2005) Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 22:55-63
9. Pashankar DS, Israel DM (2002) Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr 35:658-662
10. El-Zimaity HMT, Jackson FW, Graham DY (1997) Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 92:1858-1860
11. Choudhry U, Boyce HW Jr, Coppola D (1998) Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol 110:615-621
12. Kawai T, Kawai K, Inokuchi H, Azuma T, Sasaki Z, Seki T, Harada Y, Saito T (1987) The effect of omeprazole, a proton pump inhibitor, on ontogeny of rat gastric mucosa, with special reference to cell proliferation and DNA synthesis. Nippon Shokakibyo Gakkai Zasshi 84:1381-1388 [in Japanese]
13. Karasawa H, Tani N, Miwa T (1988) The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 23:1-8
14. Hagiwara T, Mukaisho K, Ling ZQ, Sugihara H, Hattori T: Development of pancreatic acinar cell metaplasia after successful administration of Omeprazole for 6 months in rats. Dig Dis Sci; (in press)
15. Takemoto T, Namiki M, Yachi A, Masamune O, Ishikawa M, Goto Y, Kimura K, Itoh S, Matsuo Y, Kobayashi M, Oka H, Tsuchiya M, Kurokawa K, Yokoyama I, Okabe H, Miwa T, Kohli Y, Nakazawa S, Takeuchi T, Uchino H, Miyake T, Kawai K, Kodama T, Kobayash K, Ohshiba S, Tsuji T, Kajiyama G, Shimada Y, Okazaki Y, Kishi S, Nawatai H, Tanikawa K, Hayakawa H, Hashimoto S (1989) Effect of rebamipide (OPC-12759) on gastric ulcer healing multicenter, double-blind, cetraxate controlled clinical study. Rinsho Seijin-byo 19:1265-1291
16. Nebiki H, Arakawa T, Higuchi K, Kobayashi K (1997) Quality of ulcer healing influences the relapse of gastric ulcers in humans. J Gastroenterol Hepatol 12:109-114
17. Kleine A, Kluge S, Peskar BM (1993) Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 38:1441-1449
18. Higuchi K, Arakawa T, Nebiki H, Uchida T, Fujiwara Y, Ando K, Yamasaki K, Takaishi O, Fukuda T, Kobayashi K, Kuroki T (1998) Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status. Dig Dis Sci 43(Suppl 9):99S-106S
19. Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K (1992) Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung 42:1462-1466
20. Takeuchi K, Kato S, Yasuhiro T, Yagi K (1997) Mechanism of acid secretory changes in rat stomach after damage by taurocholate: role of nitric oxide, histamine, and sensory neurons. Dig Dis Sci 42:645-653
21. Deveci MS, Deveci G (2004) Altered distribution of metaplastic Paneth, gastrin and pancreatic acinar cells in atrophic gastric mucosa with endocrine cell lesions. Tohoku J Exp Med 202:13-22
22. Jhala NC, Montemor M, Jhala D, Lu L, Talley L, Haber MM, Lechago J (2003) Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med 127:854-857
23. +)ATPase. Nature 290:159-161
24. Abraham SC, Park SJ, Cruz-Correa M, Houlihan PS, Half EE, Lynch PM, Wu TT (2004) Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps. Am J Clin Pathol 122:740-746
25. Hakanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F (1993) Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 105:15-21
26. Freston JW (1992) Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 51:102-114
27. Yoshimura K, Delbarre SG, Kraus E, Boland CR (1996) The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach. Aliment Pharmacol Ther 10:111-117
28. Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimura M, Ogawa M (1998) Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 43:253-257
29. Mattsson H, Havu N, Brautigam J, Carlsson K, Lundell L, Carlsson E (1991) Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterology 100:311-319
30. Havu N (1986) Enterochromaffin-like cell carcinoids of gastricmucosa in rats after life-long inhibition of gastric secretion. Digestion 35 (Suppl 1):42-55
31. Mine S, Iida T, Tabata T, Kishikawa H, Tanaka Y (2005) Management of symptoms in step-down therapy of gastroesophageal reflux disease. J Gastroenterol Hepatol 20:1365-1370
32. Haruma K, Ito M, Kido S, Manabe N, Kitadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K (2002) Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 47:862-867
33. Arakawa T, Higuchi K, Fujiwara Y, Watanabe T, Tominaga K, Sasaki E, Oshitani N, Yoshikawa T, Tarnawski AS (2005) Fifteenth anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 50 (Suppl 1):S3-S11
34. Genta RM (2003) Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract. Aliment Pharmacol Ther 18 (Supp1 1):8-13